1.Inflammatory Bowel Disease in Asia: The Challenges and Opportunities.
Intestinal Research 2015;13(3):188-190
No abstract available.
Asia*
;
Inflammatory Bowel Diseases*
2.Is It Safe for Patients with Inflammatory Bowel Disease to Go Abroad?.
Intestinal Research 2012;10(4):400-401
No abstract available.
Humans
;
Inflammatory Bowel Diseases
3.Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease.
Pediatric Gastroenterology, Hepatology & Nutrition 2013;16(2):65-70
Azathioprine is the most common drug used to maintain clinical remission in inflammatory bowel disease. This drug is also important as a steroid-sparing agent in steroid-dependent and chronically active inflammatory bowel disease. Nevertheless, many questions remain concerning the optimal treatment regimens of azathioprine. The dose of azathioprine has to be reduced or the therapy has to be discontinued frequently because of drug-induced toxicity. In this review, we discuss monitoring of thiopurines, adverse events, malignant complications and how to use azathioprine safely and usefully.
Azathioprine
;
Inflammatory Bowel Diseases
4.Inflammatory bowel disease in Korean.
Korean Journal of Medicine 1999;57(4):661-674
No abstract available.
Inflammatory Bowel Diseases*
5.Pivot to Asia: inflammatory bowel disease burden.
Prashant SINGH ; Ashwin ANANTHAKRISHNAN ; Vineet AHUJA
Intestinal Research 2017;15(1):138-141
No abstract available.
Asia*
;
Inflammatory Bowel Diseases*
6.Nutritional concerns in pediatric inflammatory bowel disease.
Korean Journal of Pediatrics 2016;59(6):247-251
The pathophysiology and fundamental etiologic mechanism of inflammatory bowel disease (IBD) is not well understood even though therapeutic regimens and drugs are rapidly evolutionary. IBD has complicated connections with genetic, immunologic, gut microbial, environmental, and nutritional factors. It is not clearly well known to the physicians how to feed, what nutrients are more helpful, and what food to be avoided. This review discusses the issues of growth and important nutritional concerns in the management of IBD in childhood.
Inflammatory Bowel Diseases*
;
Pediatrics
7.Micronutrient deficiencies in inflammatory bowel disease: trivial or crucial?.
Intestinal Research 2016;14(2):109-110
No abstract available.
Inflammatory Bowel Diseases*
;
Micronutrients*
8.What Are the Major Changes in Korean Inflammatory Bowel Disease Surgery?.
Annals of Coloproctology 2018;34(6):277-279
No abstract available.
Inflammatory Bowel Diseases*
9.The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease
Ana Luiza BIANCARDI ; Leandro Lopes TRONCOSO ; Haroldo Vieira DE MORAES JR ; Cyrla ZALTMAN
Intestinal Research 2019;17(1):153-154
No abstract available.
Humans
;
Inflammatory Bowel Diseases
10.To study the clinical characteristics, endoscopic imaged, factors favorable for stimulative intestinal syndrome
Journal of Practical Medicine 2003;469(12):41-43
158 patients with the syndrome of stimulative bowel were studied at the Hospital 198 from May 1999 to March 2000. Colonoscopy showed an incidence of 12.9% of stimulative bowel syndrom, the condition was more common in female than in male subjects with a highest rate of 42.4$ in the 40-49 years old group. Psychologic symptoms of stimulative bowel syndroms were nervousness 70.8%, anxiety 60.1%, abdomen pain 93%, signs of circulation dysturbance 98%. Related factors of the disease were food 71.5%, stress 35.4%. Endoscopic images showed colon constraction in 86.1%, abundant secretion of mucus substances in 34.8%
Syndrome
;
Inflammatory Bowel Diseases
;
Colonoscopy
Result Analysis
Print
Save
E-mail